137 related articles for article (PubMed ID: 36193308)
1. Prominin 1 Significantly Correlated with Bone Metastasis of Breast Cancer and Influenced the Patient's Prognosis.
Yu CC; Wu YN; Hu KM; Zhang SZ
Biomed Res Int; 2022; 2022():4123622. PubMed ID: 36193308
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer.
Li JJ; Wang S; Guan ZN; Zhang JX; Zhan RX; Zhu JL
Pathol Oncol Res; 2022; 28():1610538. PubMed ID: 36405393
[No Abstract] [Full Text] [Related]
3. Nomogram Models Based on the Gene Expression in Prediction of Breast Cancer Bone Metastasis.
Fan TD; Bei DK; Li SW
J Healthc Eng; 2022; 2022():8431946. PubMed ID: 36046013
[TBL] [Abstract][Full Text] [Related]
4. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
Li L; Liu ZP
J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
[TBL] [Abstract][Full Text] [Related]
5. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
6. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
Lu J; Hu F; Zhou Y
Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
[TBL] [Abstract][Full Text] [Related]
7. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
8. PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis.
Saha SK; Islam SMR; Kwak KS; Rahman MS; Cho SG
Cancer Gene Ther; 2020 Apr; 27(3-4):147-167. PubMed ID: 31164716
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
10. Identification and Prognostic Value Exploration of Cyclophosphamide (Cytoxan)-Centered Chemotherapy Response-Associated Genes in Breast Cancer.
Du J; Dong Y; Li Y
DNA Cell Biol; 2021 Nov; 40(11):1356-1368. PubMed ID: 34704810
[TBL] [Abstract][Full Text] [Related]
11. Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer.
Liu J; Li S; Lin L; Jiang Y; Wan Y; Zhou S; Cheng W
Cancer Biomark; 2020; 27(2):213-223. PubMed ID: 32083574
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes.
Han B; Zhang H; Zhu Y; Han X; Wang Z; Gao Z; Yuan Y; Tian R; Zhang F; Niu R
Aging (Albany NY); 2020 Jul; 12(13):13318-13337. PubMed ID: 32649310
[TBL] [Abstract][Full Text] [Related]
13. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
14. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
15. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
[TBL] [Abstract][Full Text] [Related]
16. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
Wang Z; Wang F
Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
[TBL] [Abstract][Full Text] [Related]
17. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
Front Oncol; 2021; 11():743840. PubMed ID: 34722297
[TBL] [Abstract][Full Text] [Related]
18. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
19. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.
Alshabi AM; ; Shaikh IA; Vastrad C
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
